Literature DB >> 31645445

Reverse Genetics System for a Human Group A Rotavirus.

Takahiro Kawagishi1, Jeffery A Nurdin1, Misa Onishi1, Ryotaro Nouda1, Yuta Kanai1, Takeshi Tajima2,3, Hiroshi Ushijima4, Takeshi Kobayashi5.   

Abstract

Group A rotavirus (RV) is a major cause of acute gastroenteritis in infants and young children worldwide. Recently, we established an entirely plasmid-based reverse genetics system for simian RV strain SA11. Although that system was robust enough to generate reassortant RVs, including human RV gene segments, and enabled better understanding of the biological differences between animal and human RV strains, a complete reverse genetics system for human RV strains is desirable. Here, we established a plasmid-based reverse genetics system for G4P[8] human RV strain Odelia. This technology was used to generate a panel of monoreassortant viruses between human and simian RV strains for all of the 11 gene segments demonstrating full compatibility between human and simian RV strains. Furthermore, we generated recombinant viruses lacking the C-terminal region of the viral nonstructural protein NSP1 and used it to define the biological function of the interaction between NSP1 and its target protein β-transducin repeat-containing protein (β-TrCP) during viral replication. While the NSP1 truncation mutant lacking the C-terminal 13 amino acids displayed lower β-TrCP degradation activity, it replicated as efficiently as the wild-type virus. In contrast, the truncation mutant lacking the C-terminal 166 amino acids of NSP1 replicated poorly, suggesting that the C-terminal region of NSP1 plays critical roles in viral replication. The system reported here will allow generation of engineered recombinant virus harboring desired mutations, increase our understanding of the molecular biology of human RV, and facilitate development of novel therapeutics and vaccines.IMPORTANCE Reverse genetics, an approach used to generate viruses from cloned cDNA, has increased our understanding of virus biology. Worldwide research led to the development of an entirely plasmid-based reverse genetics system for the simian RV laboratory strain. Although the technique allows generation of gene-modified recombinant RVs, biological differences between animal and human RVs mean that reverse genetics systems for human RV strains are still needed. Here, we describe a reverse genetics system for the high-yield human RV strain Odelia, which replicates efficiently and is suitable for in vitro molecular studies. Monoreassortant viruses between simian and human RV strains and NSP1 mutant viruses generated by the rescue system enabled study of the biological functions of viral gene segments. This human RV reverse genetics system will facilitate study of RV biology and development of vaccines and vectors.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  reverse genetics system; rotavirus; virus-host interactions

Mesh:

Substances:

Year:  2020        PMID: 31645445      PMCID: PMC6955264          DOI: 10.1128/JVI.00963-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

Review 1.  Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs.

Authors:  Jon R Gentsch; Ashley R Laird; Brittany Bielfelt; Dixie D Griffin; Krisztian Banyai; Madhu Ramachandran; Vivek Jain; Nigel A Cunliffe; Osamu Nakagomi; Carl D Kirkwood; Thea K Fischer; Umesh D Parashar; Joseph S Bresee; Baoming Jiang; Roger I Glass
Journal:  J Infect Dis       Date:  2005-09-01       Impact factor: 5.226

Review 2.  Effectiveness of Rotavirus Vaccination: A Systematic Review of the First Decade of Global Postlicensure Data, 2006-2016.

Authors:  Christine L Jonesteller; Eleanor Burnett; Catherine Yen; Jacqueline E Tate; Umesh D Parashar
Journal:  Clin Infect Dis       Date:  2017-09-01       Impact factor: 9.079

3.  Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread.

Authors:  Jelle Matthijnssens; Elisabeth Heylen; Mark Zeller; Mustafizur Rahman; Philippe Lemey; Marc Van Ranst
Journal:  Mol Biol Evol       Date:  2010-06-03       Impact factor: 16.240

4.  Rotavirus vaccines: safety, efficacy and public health impact.

Authors:  J Gray
Journal:  J Intern Med       Date:  2011-07-03       Impact factor: 8.989

5.  Diversity of interferon antagonist activities mediated by NSP1 proteins of different rotavirus strains.

Authors:  Michelle M Arnold; John T Patton
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

6.  Roles of VP4 and NSP1 in determining the distinctive replication capacities of simian rotavirus RRV and bovine rotavirus UK in the mouse biliary tract.

Authors:  Ningguo Feng; Adrish Sen; Marie Wolf; Phuoc Vo; Yasutaka Hoshino; Harry B Greenberg
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

7.  Immune response of infants and children to low-passage bovine rotavirus (strain WC3).

Authors:  H F Clark; T Furukawa; L M Bell; P A Offit; P A Perrella; S A Plotkin
Journal:  Am J Dis Child       Date:  1986-04

8.  Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.

Authors:  K Zaman; Duc Anh Dang; John C Victor; Sunheang Shin; Md Yunus; Michael J Dallas; Goutam Podder; Dinh Thiem Vu; Thi Phuong Mai Le; Stephen P Luby; Huu Tho Le; Michele L Coia; Kristen Lewis; Stephen B Rivers; David A Sack; Florian Schödel; A Duncan Steele; Kathleen M Neuzil; Max Ciarlet
Journal:  Lancet       Date:  2010-08-06       Impact factor: 79.321

9.  Human Intestinal Enteroids: a New Model To Study Human Rotavirus Infection, Host Restriction, and Pathophysiology.

Authors:  Kapil Saxena; Sarah E Blutt; Khalil Ettayebi; Xi-Lei Zeng; James R Broughman; Sue E Crawford; Umesh C Karandikar; Narayan P Sastri; Margaret E Conner; Antone R Opekun; David Y Graham; Waqar Qureshi; Vadim Sherman; Jennifer Foulke-Abel; Julie In; Olga Kovbasnjuk; Nicholas C Zachos; Mark Donowitz; Mary K Estes
Journal:  J Virol       Date:  2015-10-07       Impact factor: 5.103

10.  Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonism.

Authors:  Joel W Graff; Khalil Ettayebi; Michele E Hardy
Journal:  PLoS Pathog       Date:  2009-01-30       Impact factor: 6.823

View more
  8 in total

Review 1.  Plasmid-based reverse genetics for probing phosphorylation-dependent viroplasm formation in rotaviruses.

Authors:  Jeanette M Criglar; Sue E Crawford; Mary K Estes
Journal:  Virus Res       Date:  2020-10-11       Impact factor: 3.303

2.  Reverse Genetics Approach for Developing Rotavirus Vaccine Candidates Carrying VP4 and VP7 Genes Cloned from Clinical Isolates of Human Rotavirus.

Authors:  Yuta Kanai; Misa Onishi; Takahiro Kawagishi; Pimfhun Pannacha; Jeffery A Nurdin; Ryotaro Nouda; Moeko Yamasaki; Tina Lusiany; Pattara Khamrin; Shoko Okitsu; Satoshi Hayakawa; Hirotaka Ebina; Hiroshi Ushijima; Takeshi Kobayashi
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

3.  An Optimized Reverse Genetics System Suitable for Efficient Recovery of Simian, Human, and Murine-Like Rotaviruses.

Authors:  Liliana Sánchez-Tacuba; Ningguo Feng; Nathan J Meade; Kenneth H Mellits; Philippe H Jaïs; Linda L Yasukawa; Theresa K Resch; Baoming Jiang; Susana López; Siyuan Ding; Harry B Greenberg
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

Review 4.  Treading a HOSTile path: Mapping the dynamic landscape of host cell-rotavirus interactions to explore novel host-directed curative dimensions.

Authors:  Upayan Patra; Urbi Mukhopadhyay; Arpita Mukherjee; Shanta Dutta; Mamta Chawla-Sarkar
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

5.  Generation of Simian Rotavirus Reassortants with VP4- and VP7-Encoding Genome Segments from Human Strains Circulating in Africa Using Reverse Genetics.

Authors:  Alexander Falkenhagen; Corinna Patzina-Mehling; Ashish K Gadicherla; Amy Strydom; Hester G O'Neill; Reimar Johne
Journal:  Viruses       Date:  2020-02-11       Impact factor: 5.048

6.  Rescue of Infectious Rotavirus Reassortants by a Reverse Genetics System Is Restricted by the Receptor-Binding Region of VP4.

Authors:  Alexander Falkenhagen; Marno Huyzers; Alberdina A van Dijk; Reimar Johne
Journal:  Viruses       Date:  2021-02-25       Impact factor: 5.048

Review 7.  Re-Examining Rotavirus Innate Immune Evasion: Potential Applications of the Reverse Genetics System.

Authors:  Avan Antia; Amanda N Pinski; Siyuan Ding
Journal:  mBio       Date:  2022-06-14       Impact factor: 7.786

Review 8.  Human Rotavirus Reverse Genetics Systems to Study Viral Replication and Pathogenesis.

Authors:  Satoshi Komoto; Saori Fukuda; Takayuki Murata; Koki Taniguchi
Journal:  Viruses       Date:  2021-09-08       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.